These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27029288)

  • 41. [Procalcitonin-guided algorithms of antibiotic therapy in community-acquired lower respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials].
    Zhang L; Huang J; Xu T; Lin Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Apr; 35(4):275-82. PubMed ID: 22781200
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Guidance of antibiotic therapy with procalcitonin in lower respiratory tract infections: insights into the ProHOSP study.
    Schuetz P; Christ-Crain M; Albrich W; Zimmerli W; Mueller B;
    Virulence; 2010; 1(2):88-92. PubMed ID: 21178422
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Procalcitonin guidance for reduction of antibiotic use in low-risk outpatients with community-acquired pneumonia.
    Long W; Deng X; Zhang Y; Lu G; Xie J; Tang J
    Respirology; 2011 Jul; 16(5):819-24. PubMed ID: 21507143
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Procalcitonin-Guided Antibiotic Prescribing for Acute Exacerbations of Chronic Obstructive Pulmonary Disease in the Emergency Department.
    Nguyen LJ; Varker A; Slaughter P; Boyle D; Nekahi N
    Fed Pract; 2021 Jun; 38(6):264-269. PubMed ID: 34733073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness and cost-effectiveness of antibiotic treatments for community acquired pneumonia (CAP) and acute exacerbations of chronic bronchitis (AECB).
    Lavoie F; Blais L; Castilloux AM; Scalera A; LeLorier J
    Can J Clin Pharmacol; 2005; 12(2):e212-7. PubMed ID: 15998960
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ineffectiveness of procalcitonin-guided antibiotic therapy in severely critically ill patients: A meta-analysis.
    Peng F; Chang W; Xie JF; Sun Q; Qiu HB; Yang Y
    Int J Infect Dis; 2019 Aug; 85():158-166. PubMed ID: 31229612
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk stratification and prediction value of procalcitonin and clinical severity scores for community-acquired pneumonia in ED.
    Zhou H; Guo S; Lan T; Ma S; Zhang F; Zhao Z
    Am J Emerg Med; 2018 Dec; 36(12):2155-2160. PubMed ID: 29691103
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Implementation of Procalcitonin in Antibiotic Stewardship: Derivation of a Consensus Algorithm for Procalcitonin Use in Clinical Practice.
    Park DW; Choi JY; Kim CJ; Kim JH; Kim HB; Lee DG
    Infect Chemother; 2022 Dec; 54(4):621-636. PubMed ID: 36596678
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The value of serum procalcitonin in treatment of community acquired pneumonia in outpatient].
    Long W; Deng XQ; Tang JG; Xie J; Zhang YC; Zhang Y; Gao YY; Lu G
    Zhonghua Nei Ke Za Zhi; 2009 Mar; 48(3):216-9. PubMed ID: 19576090
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PROCalcitonin-based algorithm for antibiotic use in Acute Pancreatitis (PROCAP): study protocol for a randomised controlled trial.
    Siriwardena AK; Jegatheeswaran S; Mason JM; Baltatzis M; Chan A; Sheen AJ; O'Reilly D; Jamdar S; Deshpande R; de Liguori Carino N; Satyadas T; Qamruddin A; Hayden K; Parker MJ; Butler J; Rajai A; McIntyre B
    Trials; 2019 Jul; 20(1):463. PubMed ID: 31358032
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Procalcitonin-guided antibiotic therapy in AECOPD patients: Overview of systematic reviews.
    Di J; Li X; Xie Y; Yang S; Yu X
    Clin Respir J; 2021 Jun; 15(6):579-594. PubMed ID: 33683808
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An algorithm for PCT-guided antimicrobial therapy: a consensus statement by Japanese experts.
    Ito A; Shime N; Fujishima S; Fujitani S; Komiya K; Schuetz P
    Clin Chem Lab Med; 2023 Feb; 61(3):407-411. PubMed ID: 36453810
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Procalcitonin Biomarker Algorithm Reduces Antibiotic Prescriptions, Duration of Therapy, and Costs in Chronic Obstructive Pulmonary Disease: A Comparison in the Netherlands, Germany, and the United Kingdom.
    van der Maas ME; Mantjes G; Steuten LM
    OMICS; 2017 Apr; 21(4):232-243. PubMed ID: 28388301
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis.
    Hoshina T; Nanishi E; Kanno S; Nishio H; Kusuhara K; Hara T
    J Infect Chemother; 2014 Oct; 20(10):616-20. PubMed ID: 25027057
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Procalcitonin guidance in patients with lower respiratory tract infections: a systematic review and meta-analysis.
    Hey J; Thompson-Leduc P; Kirson NY; Zimmer L; Wilkins D; Rice B; Iankova I; Krause A; Schonfeld SA; DeBrase CR; Bozzette S; Schuetz P
    Clin Chem Lab Med; 2018 Jul; 56(8):1200-1209. PubMed ID: 29715176
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.
    Christ-Crain M; Jaccard-Stolz D; Bingisser R; Gencay MM; Huber PR; Tamm M; Müller B
    Lancet; 2004 Feb; 363(9409):600-7. PubMed ID: 14987884
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Procalcitonin as a biomarker of acute lower respiratory tract infections.
    Wróblewski T; Marcisz C
    Expert Opin Med Diagn; 2009 Jan; 3(1):67-79. PubMed ID: 23495964
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of biomarkers in the management of antibiotic therapy: an expert panel review II: clinical use of biomarkers for initiation or discontinuation of antibiotic therapy.
    Quenot JP; Luyt CE; Roche N; Chalumeau M; Charles PE; Claessens YE; Lasocki S; Bedos JP; Péan Y; Philippart F; Ruiz S; Gras-Leguen C; Dupuy AM; Pugin J; Stahl JP; Misset B; Gauzit R; Brun-Buisson C
    Ann Intensive Care; 2013 Jul; 3(1):21. PubMed ID: 23830525
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
    de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
    Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How to reduce antibiotic consumption for community-acquired pneumonia?
    Montassier E; Goffinet N; Potel G; Batard E
    Med Mal Infect; 2013 Feb; 43(2):52-9. PubMed ID: 23433607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.